Literature DB >> 28025990

Focal cortical dysplasia: Molecular disturbances and clinicopathological classification (Review).

Monika Siedlecka1, Wiesława Grajkowska2, Ryszard Galus1, Bożenna Dembowska-Bagińska3, Jarosław Jóźwiak1.   

Abstract

Focal cortical dysplasia (FCD) is one of the most important causes of drug-resistant epilepsy in paediatric patients, particularly in those below the age of 3. Even though over 40 years have passed since the first description of the entity by Taylor, the exact mechanisms causing these cortical abnormalities remain unelucidated. In this review, we summarise the current knowledge on clinical and histopathological aspects, taking into account the new classification system proposed by the International League Against Epilepsy. We focus on the clinicopathological associations and differences in post-surgical outcome among FCD subtypes, in particular isolated FCD vs. FCD associated with principal lesions, which have not been summarised to date. We also recapitulate genetic studies, pointing to the possible mechanisms of the cortical dysregulation and drug resistance, and summarise novel factors which may contribute to epileptogenesis in FCD. Furthermore, we compare FCD type IIB (FCDIIB) with brain tumours found in a neurocutaneous disorder, tuberous sclerosis, as we evaluate the hypothesis that FCD IIB may be a local form of this disease.

Entities:  

Mesh:

Year:  2016        PMID: 28025990     DOI: 10.3892/ijmm.2016.2760

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  2 in total

1.  Pathogenesis and Therapeutic Targets of Focal Cortical Dysplasia Based on Bioinformatics Analysis.

Authors:  Ying Kan; Lijuan Feng; Yukun Si; Ziang Zhou; Wei Wang; Jigang Yang
Journal:  Neurochem Res       Date:  2022-08-09       Impact factor: 4.414

2.  Reorganization of Parvalbumin Immunopositive Perisomatic Innervation of Principal Cells in Focal Cortical Dysplasia Type IIB in Human Epileptic Patients.

Authors:  Cecília Szekeres-Paraczky; Péter Szocsics; Loránd Erőss; Dániel Fabó; László Mód; Zsófia Maglóczky
Journal:  Int J Mol Sci       Date:  2022-04-25       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.